Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant RSV (Palivizumab Biosimilar) antibody

Research Grade Reactivity: Human ELISA Host: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7487813
  • Target See all RSV (Palivizumab Biosimilar) products
    RSV (Palivizumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    Clonality
    • 1
    Monoclonal
    Conjugate
    • 1
    This RSV (Palivizumab Biosimilar) antibody is un-conjugated
    Application
    • 1
    • 1
    ELISA
    Purpose
    Palivizumab Biosimilar - Anti-RSV mAb
    Characteristics
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Grade
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Storage
    -80 °C
    Storage Comment
    store at -80°C
  • Target
    RSV (Palivizumab Biosimilar)
    Abstract
    RSV (Palivizumab Biosimilar) Products
    Target Type
    Biosimilar
    Background
    MEDI-493, Synagis
    Palivizumab is a humanized monoclonal antibody of isotype IgG1k produced by recombinant DNA technology. It targets the epitope in the A antigenic site of the respiratory syncytial virus (RSV) F protein.
    CAS-No
    188039-54-5
You are here:
Support